You are viewing: UK Radioisotope Identification Devices Market analysis

The UK Radioisotope Identification Devices Market was valued at $99 Million in 2026 and projected to reach to $134.3 Million by 2031, representing a compound annual growth rate of 6.3%. The UK radioisotope identification devices market is poised for sustained growth through 2031, driven by increasing demand for precision diagnostics and the NHS's commitment to modernizing nuclear medicine capabilities.

UK Radioisotope Identification Devices Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK Radioisotope Identification Devices Market Trends and Insights

  • The UK market benefits from strong healthcare infrastructure, regulatory frameworks supporting nuclear medicine, and increasing adoption of advanced diagnostic technologies across NHS facilities and private healthcare providers.
  • The UK's commitment to modernizing medical imaging capabilities and enhancing radiation safety protocols continues to drive demand for sophisticated radioisotope identification solutions. Growth in the UK market is underpinned by rising prevalence of cancer and cardiovascular diseases requiring nuclear medicine diagnostics, coupled with investments in healthcare technology infrastructure.
  • The UK's regulatory environment, governed by the Health and Safety Executive and the Environment Agency, ensures stringent standards for radioisotope handling and identification, creating sustained demand for compliant devices.
  • Between 2026 and 2031, the UK is expected to see increased deployment of these devices in hospitals, diagnostic centers, and research institutions, supported by government healthcare spending initiatives and private sector expansion..

Key Market Statistics

  • CAGR (2026-2031) 6.3% CAGR
  • Market Size, 2026 ~USD 99 Million
  • Forecast, 2031 ~USD 134.3 Million
  • Country UK

UK Radioisotope Identification Devices Market Overview

Market Valuation :

The UK radioisotope identification devices market is valued at $99.0 million in 2026 and is projected to reach $134.3 million by 2031, demonstrating robust growth in the healthcare sector.

Strong CAGR Performance :

The UK market is expanding at a compound annual growth rate of 6.3% from 2026 to 2031, outpacing many European counterparts and reflecting increasing investment in nuclear medicine infrastructure.

NHS Integration & Adoption :

NHS facilities across the UK are increasingly adopting advanced radioisotope identification devices, driven by modernization initiatives and the need for improved diagnostic accuracy in oncology and cardiology departments.

Regulatory Support & Infrastructure :

The UK's established regulatory frameworks for nuclear medicine, combined with world-class healthcare infrastructure, create a favorable environment for device manufacturers and healthcare providers to deploy cutting-edge identification technologies.

UK Radioisotope Identification Devices Market Dynamics

  • Investment in healthcare technology and the expansion of PET-CT and SPECT imaging centers across the UK will further accelerate market penetration.
  • Private healthcare providers are also investing significantly in these devices to enhance competitive positioning and patient outcomes.
  • Regulatory support from the MHRA and alignment with European standards will facilitate market expansion, while skilled workforce development in nuclear medicine will support widespread adoption across both urban and regional healthcare facilities..

Related Ecosystem

Analytical And Scientific Instrumentation

Top Technologies
  • Environmental Testing
  • Gas Chromatography
  • Polymerase Chain Reaction (PCR)
  • Automated Liquid Handling Systems
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Merck KGaA
  • Shimadzu Corporation

    Key Takeaways

    • The UK radioisotope identification devices market is valued at $99.0 million in 2026 and will reach $134.3 million by 2031 at a 6.3% CAGR.
    • The UK's robust healthcare infrastructure and regulatory compliance requirements drive sustained demand for advanced radioisotope identification technologies.
    • Rising incidence of cancer and cardiovascular diseases in the UK is increasing the need for nuclear medicine diagnostics and identification devices.
    • The UK market is supported by government healthcare investments and private sector expansion in diagnostic imaging capabilities through 2031.

    Radioisotope Identification Devices Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment SPECTROSCOPIC PERSONAL RADIATION DETECTORS (Product Type)
    Forecast Period 2026–2031
    Growth Rate CAGR of 6.9% from 2026 to 2031
    Largest Segment HOMELAND SECURITY & BORDER PROTECTION (Application)
    Market Size Base Year (Billions) ~USD 2.04 (2026)
    Revenue Forecast (Billions) ~USD 2.85 (2031)
    Segments Covered Product Type, Application, End User

    UK Radioisotope Identification Devices Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product Type

    • Fixed Radiation Monitoring Systems
    • Handheld Personal Radiation Detectors
    • Other Products
    • Personal Radiation Detectors
    • Radioisotope Identification Devices
    • Spectroscopic Personal Radiation Detectors

    By Application

    • Cbrn Mission Users
    • Environmental Monitoring & Radiation Safety
    • Homeland Security & Border Protection
    • Industrial Applications
    • Medical & Healthcare
    • Nuclear Power Plants & Fuel Cycle Facilities
    • Other Applications

    By End User

    • Government & Defense Agencies
    • Hospitals & Diagnostic Centers
    • Industrial Facilities
    • Nuclear Facilities
    • Other End Users
    • Research Institutes & Universities

    Target Audience

    • Medical Device Manufacturers : Manufacturers need UK market data to develop localized go-to-market strategies, understand NHS procurement requirements, and identify partnership opportunities with healthcare providers and distributors.
    • NHS Trust Procurement Teams : NHS procurement professionals require market intelligence to benchmark device costs, evaluate supplier options, and justify capital expenditure for radioisotope identification technology investments.
    • Private Healthcare Operators : Private hospital chains and diagnostic centers need UK-specific market insights to assess competitive positioning, forecast demand, and make informed investment decisions in nuclear medicine capabilities.
    • Healthcare Investors & Consultants : Investment firms and management consultants require detailed UK market analysis to evaluate acquisition targets, assess growth potential, and develop investment theses in the medical technology sector.
    • Regulatory & Policy Bodies : UK health authorities and policy makers need market data to understand technology adoption trends, assess healthcare infrastructure needs, and develop evidence-based policies for nuclear medicine services.

    Key Companies in the UK Radioisotope Identification Devices Market

    CompanyHQOwnershipStrongest segments
    MIRION TECHNOLOGIES INC.United StatesPublic CompanyHandheld RIIDs,Fixed RIID and portal systems,Spectroscopic systems and lab analyzers,
    THERMO FISHER SCIENTIFICUnited StatesPublic CompanyHandheld RIIDs,Spectroscopic RIIDs,Personal RIIDs,
    TELEDYNE FLIRUnited StatesPrivate CompanyPersonal,Handheld,Fixed,
    AMETEK, INC.United StatesPublic CompanySpectroscopic RIIDs,Fixed RIID Systems,Handheld RIIDs,
    HITACHI, LTD.JapanPublic CompanyPersonal,Handheld,Fixed,
    KROMEK GROUP PLCUnited KingdomPublic CompanySpectroscopic RIIDs (handheld, backpack, fixed spectroscopic nodes),Handheld non-spectroscopic RIIDs and survey meters,Personal radiation detectors and pagers,

    MIRION TECHNOLOGIES INC.

    Mirion Technologies Inc. is a U.S.-based public company founded in 2005 that employs 3,281 people. The company operates in the radiation detection and measurement sector.

    THERMO FISHER SCIENTIFIC

    Thermo Fisher Scientific is a U.S.-based public company founded in 1956 with 125,000 employees. It is a major provider of laboratory equipment, reagents, and analytical instruments.

    TELEDYNE FLIR

    Teledyne FLIR is a U.S.-based private company founded in 1978 with 4,179 employees. The company specializes in thermal imaging and infrared technology solutions.

    AMETEK, INC.

    AMETEK, Inc. is a U.S.-based public company founded in 1930 with 22,500 employees. The company manufactures electronic instruments and electromechanical devices for industrial applications.

    HITACHI, LTD.

    Hitachi, Ltd. is a Japanese-based public company founded in 1910 with 287,901 employees. The company is a diversified conglomerate operating across multiple industrial and technology sectors.

    KROMEK GROUP PLC

    Kromek Group PLC is a United Kingdom-based public company founded in 2003 with 162 employees. The company specializes in radiation detection and imaging technology.

    Reasons to Buy this Report

    • UK-Specific Market Sizing : Obtain precise valuation data for the UK market ($99M in 2026) with detailed forecasts through 2031, enabling accurate budgeting and investment planning for UK healthcare operations.
    • NHS Procurement Insights : Understand adoption patterns across NHS trusts and private healthcare providers in the UK, identifying key procurement cycles and decision-making frameworks specific to the British healthcare system.
    • Competitive Landscape Analysis : Gain intelligence on UK-based and international competitors operating in the radioisotope identification space, including market share distribution and strategic positioning within the UK healthcare sector.
    • Regulatory & Compliance Framework : Access detailed information on MHRA regulations, CE marking requirements, and UK-specific compliance standards that impact device approval, market entry, and operational requirements.
    • Growth Opportunity Identification : Identify high-growth segments within the UK market, including emerging applications in oncology, cardiology, and research institutions, with actionable insights for market expansion strategies.

    Frequently asked questions

    What is the current size of the UK radioisotope identification devices market?

    The UK radioisotope identification devices market is valued at $99.0 million in 2026 and is expected to grow to $134.3 million by 2031.

    What is the projected growth rate for the UK market?

    The UK radioisotope identification devices market is projected to grow at a compound annual growth rate (CAGR) of 6.3% from 2026 to 2031.

    What factors are driving growth in the UK market?

    Key drivers include rising prevalence of cancer and cardiovascular diseases, strong healthcare infrastructure, regulatory compliance requirements, and government investments in healthcare technology modernization across the UK.

    Which sectors in the UK are adopting radioisotope identification devices?

    The UK market includes adoption across NHS hospitals, private healthcare providers, diagnostic imaging centers, research institutions, and specialized nuclear medicine facilities.

    How does UK regulation impact the radioisotope identification devices market?

    The UK's Health and Safety Executive and Environment Agency enforce stringent standards for radioisotope handling and identification, creating sustained demand for compliant and advanced identification devices.

    RESEARCH METHODOLOGY

    The research methodology for analyzing the global radioisotope identification devices market is clearly detailed on the website, outlining the structured processes and best practices followed for data collection, validation, and analysis. This transparent and systematic approach ensures high accuracy and reliability of the insights presented. Such clarity allows stakeholders to assess the robustness of the findings, conclusions, and recommendations, ultimately enabling confident and well-informed decision-making.

    Secondary Research

    For this secondary research, we relied on diverse sources such as D&B Hoovers, Bloomberg Businessweek, Factiva, white papers, annual reports, company filings, investor presentations, and SEC filings. This in-depth approach helped build a robust database of key players in the industry. The database provides essential insights into established companies, detailed multi-level market segmentation, trends within each segment, notable mergers & acquisitions, and the impact of cutting-edge technological innovations shaping the radioisotope identification devices market.

    Primary Research

    The primary research involved both qualitative and quantitative approaches and was conducted in depth with participants from both the supply and demand sides through interviews.
    On the supply side, interviews were conducted with senior-level executives such as CEOs, vice presidents, product managers, R&D heads, and sales directors from leading companies involved in the development and manufacturing of radioisotope identification devices and radiation detection technologies. These companies include manufacturers of RIIDs, spectroscopic detectors, semiconductor and scintillation-based detection systems, as well as providers of integrated radiation detection solutions. In addition, insights were gathered from original equipment manufacturers (OEMs) and system integrators supplying RIIDs for homeland security, nuclear facilities, emergency response, and industrial safety applications.
    On the demand side, interviews were conducted with key end users such as homeland security officials, border protection agencies, emergency responders, nuclear facility operators, healthcare professionals involved in nuclear medicine, and radiation safety officers. Additional stakeholders included representatives from law enforcement agencies, customs and port authorities, environmental monitoring organizations, industrial safety teams, and research institutions. Feedback was also collected from distributors, system integrators, and government organizations responsible for radiation safety, nuclear regulation, and critical infrastructure protection.
    Overall, this research provided valuable insights into market segmentation, key players, trends, dynamics, and growth of drivers in the market.
    A breakdown of the primary respondents is provided below:

    Radioisotope Identification Devices Market  Size, and Share

    Note 1: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
    Note 2: Companies are classified into tiers based on their total revenue. As of 2024 Tier 1 = >USD 1 billion, Tier 2 = <USD 500 million, and Tier 3 = <USD 100 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The report offers an in-depth analysis of the radioisotope identification devices market, identifying key players through both primary and secondary research. Secondary research drew on annual and financial reports from major companies, while primary research included detailed interviews with key opinion leaders such as CEOs, directors, and senior marketing executives.
    To estimate the global market value, a segment-based methodology was applied, using revenue data from leading solution providers. This involved:

    • Identifying major participants in the global radioisotope identification devices market
    • Reviewing their reported annual revenues, whether directly related to radioisotope identification devices or reflecting broader business units and product lines.

    The data was then projected to arrive at the overall value for the radioisotope identification devices market.

    Radioisotope Identification Devices Market : Top-Down and Bottom-Up Approach

    Radioisotope Identification Devices Market  Top Down and Bottom Up Approach

    Data Triangulation

    The research approach involved dividing the global radioisotope identification devices market into different participant groups and categories. Data triangulation and segmentation methods were applied to ensure the accuracy of information across all market segments. Multiple analyses were carried out to assess both the demand and supply aspects of the market. By combining top-down and bottom-up approaches, the study provided a comprehensive understanding of the radioisotope identification devices market.

    Market Definition

    The radioisotope identification devices (RIIDs) market refers to the global industry focused on the development, production, and deployment of portable and handheld radiation detection systems that are capable of not only detecting radiation but also accurately identifying specific radioactive isotopes using spectroscopic analysis. These devices are widely used across applications such as homeland security, border protection, emergency response, nuclear facilities, healthcare, and environmental monitoring to detect, classify, and assess radiological threats or materials. The market encompasses various technologies, including scintillation and semiconductor-based detectors, along with integrated software for real-time data analysis and isotope identification, enabling users to make informed decisions for safety, compliance, and threat mitigation.

    Key Stakeholders

    • RIID Manufacturers
    • Component Suppliers (scintillators, semiconductor detectors, electronics)
    • Original Equipment Manufacturers (OEMs)
    • System Integrators & Solution Providers
    • Distributors & Channel Partners
    • Raw Material and Reagent Suppliers
    • Regulatory Authorities

    Report Objectives

    • To define, describe, and forecast the global radioisotope identification devices market based on product type, application, end user, and region
    • To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and challenges), along with the current trends
    • To strategically analyze micromarkets with respect to their individual growth trends, future prospects, and contributions to the total market
    • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the revenue of the market segments for five regions: North America (US and Canada), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa
    • To profile the key players and comprehensively analyze their market shares and core competencies
    • To track and analyze competitive developments in the radioisotope identification devices market, such as acquisitions, product launches, expansions, agreements, joint ventures, alliances, and collaborations

    Available customizations:

    Based on the available market data, MarketsandMarkets offers tailored customization to meet the specific needs of a company. The following customization options are available for the global radioisotope identification devices market:

    Regional Analysis

    • Detailed analysis of the Rest of Europe radioisotope identification devices market (including Russia, Belgium, the Netherlands, Switzerland, Sweden, Austria, Portugal, and other countries)
    • Detailed analysis of the Rest of Asia Pacific radioisotope identification devices market (including Singapore, Philippines, Taiwan, New Zealand, and other countries)

    Get the Full Radioisotope Identification Devices Market Report

    Full forecast, segment splits, and company analysis for all Radioisotope Identification Devices Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status